Palisade Bio, Inc. Common Stock

– Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics

Related tickers: PALI.

U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling around 0.3% on Tuesday. The Dow traded up 0.02% to 37,741.96 while the NASDAQ fell 0.20% to 15,853.39. The S&P 500 also fell, dropping, 0.28% to 5,047.76. Check This Out: Alphabet, Toll Brothers And 2 Other Stocks Insiders Are Selling   Leading and Lagging Sectors   Information technology shares rose by 0.4% on Tuesday. In trading on Tuesday, real estate shares fell by 1.8%.   Top Headline   Industrial production in the U.S. increased by 0.4% from the prior month in March versus a revised 0.4% rise in the prior month.   Equities Trading UP   Jaguar Health, Inc. (NASDAQ: JAGX) shares shot up 52% to $0.1809 after the company signed an exclusive 5-year in-license agreement with Venture Life Group for Gelclair. Shares of WiSA Technologies, Inc. (NASDAQ: WISA) got a boost, surging 261% to $6.32 after the company announced a 5-year WiSA E licensing agreement with an HDTV/PTV brand. Palisade Bio, Inc. (NASDAQ: PALI) shares were also up, gaining 37% to $5.67 after the company announced the completion of analysis evaluating ex-vivo bioactivation of PALI-2108.   Equities Trading DOWN   Barnes & Noble Education, ...

Related tickers: PACB, JAGX, BNED, WISA, PALI, CLDI.